Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Monday, November 23, 2009, 1:30PM ET - U.S. Markets close in 2 hours and 30 minutes. Dow Up 1.20% Nasdaq Up 1.34%
Genoptix, Inc. (GXDX)At 1:14PM ET: 37.20  Up 0.74 (2.03%)  
MORE ON GXDX
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Genoptix, Inc.
1811 Aston Avenue
Carlsbad, CA 92008
United States - Map
Phone: 760-268-6200
Fax: 760-268-6201
Web Site: http://www.genoptix.com

DETAILS 
Index Membership:S&P 600 SmallCap
S&P 1500 Super Comp
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:301

BUSINESS SUMMARY 
Genoptix, Inc. provides specialized laboratory service that focus on delivering diagnostic services in the United States. Its services include COMPASS service offering, in which the company’s hematopathologists determine the appropriate diagnostic tests to be performed, and then integrates patient history and previous and current test results into a comprehensive diagnostic report; and CHART service offering, in which the hematologists and oncologists receives a detailed assessment of a patient's disease progression over time. The company also offers diagnostic services, such as professional interpretation by its hematopathologists. It focuses on marketing its specialized diagnostic services to community-based hematologists and oncologists treating malignancies of the blood and bone marrow, and other forms of cancer. The company was founded in 1999 and is based in Carlsbad, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Genoptix, Inc.


    CORPORATE GOVERNANCE 
    Genoptix, Inc.'s Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 37.1% of S&P 600 companies and 68.1% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. Tina S. Nova Ph.D., 55
    Founder, Chief Exec. Officer, Pres and Exec. Director
    $ 860.00K $ 3.00M
    Mr. Douglas A. Schuling , 49
    Chief Financial Officer, Principal Accounting Officer and Exec. VP
    $ 434.00K $ 1.04M
    Mr. Samuel D. Riccitelli , 50
    Chief Operating Officer and Exec. VP
    $ 592.00K $ 1.34M
    Dr. Christian V. Kuhlen M.D. Esq., 36
    VP, Gen. Counsel and Corp. Sec.
    $ 348.00KN/A
    Dr. Bashar Dabbas M.D., FCAP, 50
    Chairman of Hematopathology and Laboratory Director
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis